Cargando…

Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval

The association between the disease-free interval (DFI) and survival after a locoregional recurrence (LRR) or second primary (SP) breast cancer remains uncertain. The objective of this study is to clarify this association to obtain more information on expected prognosis. Women first diagnosed with e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witteveen, Annemieke, Kwast, Annemiek B. G., Sonke, Gabe S., IJzerman, Maarten J., Siesling, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393268/ https://www.ncbi.nlm.nih.gov/pubmed/25861031 http://dx.doi.org/10.1371/journal.pone.0120832

Ejemplares similares

Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
por: Witteveen, Annemieke, et al.
Publicado: (2015)

Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Evaluating the Age‐Based Recommendations for Long‐Term Follow‐Up in Breast Cancer
por: Witteveen, Annemieke, et al.
Publicado: (2020)

Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands
por: van Maaren, Marissa C., et al.
Publicado: (2022)

Risk‐based breast cancer follow‐up stratified by age
por: Witteveen, Annemieke, et al.
Publicado: (2018)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
por: Kheradmand, Ali Arab, et al.
Publicado: (2010)

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model
por: Völkel, Vinzenz, et al.
Publicado: (2021)

Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
por: Ankersmid, Jet W., et al.
Publicado: (2022)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Patterns and predictors of first and subsequent recurrence in women with early breast cancer
por: Geurts, Y. M., et al.
Publicado: (2017)

Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study
por: de Ligt, Kelly M., et al.
Publicado: (2018)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Epigenomic Alterations in Breast Carcinoma from Primary Tumor to Locoregional Recurrences
por: Moarii, Matahi, et al.
Publicado: (2014)

Survival and prognostic factors in oligometastatic breast cancer
por: van Ommen-Nijhof, Annemiek, et al.
Publicado: (2022)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany
por: Voelkel, Vinzenz, et al.
Publicado: (2019)

Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
por: Cadena-Piñeros, Enrique, et al.
Publicado: (2022)

Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences
por: Brinkhof, Sander, et al.
Publicado: (2017)

Multiple nodal locoregional recurrence of pheochromocytoma
por: Ramírez-Plaza, César Pablo, et al.
Publicado: (2015)

Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence
por: Park, Soojin, et al.
Publicado: (2015)

Locoregional progression-free survival of bone metastases from differentiated thyroid cancer
por: Luo, Jiaxin, et al.
Publicado: (2022)

Risk Factors of the Invasive Breast Cancer Locoregional Recurrence
por: Liubota, R. V., et al.
Publicado: (2015)

Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands
por: van Steenbeek, Cornelia D., et al.
Publicado: (2019)

Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes
por: Kraeima, J, et al.
Publicado: (2013)

Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model
por: Kong, Jie, et al.
Publicado: (2021)

Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy
por: Kong, Moonkyoo, et al.
Publicado: (2022)

Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Differential Prognostic Indicators for Locoregional Recurrence, Distant Recurrence, and Death of Breast Cancer
por: Chairat, Rungnapa, et al.
Publicado: (2013)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
por: Dackus, Gwen M H E, et al.
Publicado: (2021)

Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
por: Dackus, Gwen M. H. E., et al.
Publicado: (2020)

The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival
por: Höppener, Diederik J., et al.
Publicado: (2019)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival
por: Daskalakis, Kosmas, et al.
Publicado: (2022)

A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment
por: Wei, Ying-Hong, et al.
Publicado: (2022)

Correction: Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Data on distant metastasis and survival after locoregional recurrence following nipple-sparing mastectomy and immediate breast reconstruction
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

Changes in survival in de novo metastatic cancer in an era of new medicines
por: Luyendijk, Marianne, et al.
Publicado: (2023)

CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yan, Chang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_picpkleomer01e9fdklbt0d9uk